Collegium Pharmaceutical Shares Rise After 2025 Guidance-February 2024-www.financetom.com

Collegium Pharmaceutical Shares Rise After 2025 Guidance

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Collegium Pharmaceutical Shares Rise After 2025 Guidance

Jan 8, 2025 9:49 AM

12:17 PM EST, 01/08/2025 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) shares rose by nearly 13% in recent trading on Wednesday after the company provided 2025 guidance.

Collegium said it expects 2025 product revenue of between $735 million to $750 million. Analysts polled by FactSet expect $739.9 million.

Jornay PM, an attention-deficit/hyperactivity disorder drug, is positioned to be the lead growth driver, with expected net revenue of more than $135 million in 2025, Collegium said.

Price: 32.82, Change: +3.68, Percent Change: +12.63

Previous page： IBLA 2023: Rakesh Jhunjhunwala, the Big Bull of Dalal Street who always took risks Next page： IBLA 2023: Adar Poonawalla believes Serum Institute is doing well, hope to steadily build further

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

IBLA 2023: Rakesh Jhunjhunwala, the Big Bull of Dalal Street who always took risks

May 11, 2023

A chartered accountant by profession, Jhunjhunwala was attracted to the stock market right from his college years and later, unsurprisingly, went on to become a Dalal Street icon who inspired a generation of investors.

IBLA 2023: Adar Poonawalla believes Serum Institute is doing well, hope to steadily build further

May 11, 2023

Adar Poonawalla, CEO of Serum Institute of India, was in attendance the India Business Leader Awards 2023, for which he was a member of the jury tasked with selecting winners across various categories. Poonawalla said it was a great experience to be part of the distinguished group of entrepreneurs and business leaders, but also shared that some categories were harder to pick from than others.

IBLA 2023: Indian banks more resilient as they are reliant on retail deposits, says Standard Chartered's Zarin Daruwala

May 11, 2023

Zarin Daruwala, CEO of Standard Chartered Bank, said despite the global banking crisis, Indian banks have been fortunate to be "ring-fenced". This means that they have been able to weather the storm better than many of their global counterparts.

IBLA 2023: Life and legacy of Tata Group’s 6th chairman Cyrus Mistry

May 11, 2023

Of Irish descent, Cyrus Mistry was born on 4 July 1968 to a Parsi family in Bombay (now Mumbai), Maharashtra, the younger son of Indian billionaire and construction magnate Pallonji Mistry by his wife Patsy Perin Dubash.